The lawsuits, filed in multiple states, contend there's a causal link between semaglutide and a rare condition called NAION that leads to diminished eyesight. Plaintiffs want the popular weight-loss drugs to add a warning label.
The lawsuits, filed in multiple states, contend there's a causal link between semaglutide and a rare condition called NAION that leads to diminished eyesight. Plaintiffs want the popular weight-loss drugs to add a warning label.